STRN-ALK Fusion-Positive Case of Breast Cancer With Response to Alectinib

JCO Precis Oncol. 2021 Aug 11:5:PO.21.00142. doi: 10.1200/PO.21.00142. eCollection 2021 Aug.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anaplastic Lymphoma Kinase / analysis*
  • Anaplastic Lymphoma Kinase / blood
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Calmodulin-Binding Proteins / analysis*
  • Calmodulin-Binding Proteins / blood
  • Carbazoles / metabolism
  • Carbazoles / pharmacology*
  • Carbazoles / therapeutic use
  • Female
  • Humans
  • Membrane Proteins / analysis*
  • Membrane Proteins / blood
  • Middle Aged
  • Nerve Tissue Proteins / analysis*
  • Nerve Tissue Proteins / blood
  • Piperidines / metabolism
  • Piperidines / pharmacology*
  • Piperidines / therapeutic use
  • Protein Kinase Inhibitors / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Calmodulin-Binding Proteins
  • Carbazoles
  • Membrane Proteins
  • Nerve Tissue Proteins
  • Piperidines
  • Protein Kinase Inhibitors
  • STRN protein, human
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • alectinib